News
Important Only
UK's Starmer calls alleged passing of sensitive information to Epstein 'disgraceful'
LONDON, Feb 3 (Reuters) - British Prime Minister Keir Starmer told ministers on Tuesday the alleged passing on of sensitive government information by the UK's former U.S. ambassador Peter Mandelson to late sex offender Jeffrey Epstein was "disgraceful".Chairing a meeting of his top team ...Reuters
Tue, Feb 3
Eli Lilly indicates interest in purchasing up to 4.9% of Veradermics’ post‑IPO shares at the offer price
Feb 3 (Reuters) - Veradermics:VERADERMICS: ELI LILLY INDICATED INTEREST IN PURCHASING AT IPO PRICE COMMON SHARES OF UP TO 4.9% OF NUMBER OF SHARES OUTSTANDING AFTER OFFERINGVERADERMICS INC: SHARES OF COMMON STOCK TO BE PURCHASED BY ELI LILLY WILL NOT BE SUBJECT TO A LOCK-UP AGREEMENT WITH THE UNDERW...Reuters
Tue, Feb 3
Greece to soon announce social media ban for children under 15, government source says
ATHENS, Feb 3 (Reuters) - Greece is "very close" to announcing a social media ban for children aged under 15, a senior government source told Reuters on Tuesday.Spain said on Tuesday that it plans to ban social media for those aged under 16 and will create a law to hold social media executiv...Reuters
Tue, Feb 3
Hubbell's quarterly profit rises on strong data center product demand
Feb 3 (Reuters) - Hubbell HUBB.N posted a rise in fourth-quarter profit on Tuesday, helped by strong demand for its electrical equipment from data centers. Shelton, Connecticut-based Hubbell, whose products include wiring and lighting systems, has benefited from the global rise in data center constr...Reuters
Tue, Feb 3
Sanofi - Rezurock Now Reimbursed In Ontario And British Columbia For People Living With Chronic Graft-Versus-Host Disease (Gvhd)
Feb 3 (Reuters) - Sanofi SA SASY.PA:SANOFI - REZUROCK NOW REIMBURSED IN ONTARIO AND BRITISH COLUMBIA FOR PEOPLE LIVING WITH CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD)Reuters
Tue, Feb 3
Kratos Wins Aviation System, Warfighter Contract Awards Worth Up To $65 Million
Feb 3 (Reuters) - Kratos Defense and Security Solutions Inc KTOS.O:KRATOS RECENTLY RECEIVED AVIATION SYSTEM AND RELATED WARFIGHTER CONTRACT AWARDS WITH TOTAL POTENTIAL VALUE OF APPROXIMATELY $65 MILLIONKRATOS DEFENSE AND SECURITY SOLUTIONS INC - CONTRACTS INCLUDE AWARDS FROM U.S. DEPARTMENT OF WAR A...Reuters
Tue, Feb 3
Olympics-Curling-Team US bring 'the calm and the fire' to mixed doubles competition
CORTINA D'AMPEZZO, Feb 3 (Reuters) - American curlers Korey Dropkin and Cory Thiesse may be polar opposites on the ice, but they feel their contrasting personalities could create the perfect mix as they head into the mixed doubles competition at the Milano Cortina Winter Olympics.The pair, world...Reuters
Tue, Feb 3
Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer
Feb 3 (Reuters) - GSK plc GSK.L:GSK - QUEBEC TO REIMBURSE JEMPERLI PLUS CHEMOTHERAPY VIA RAMQ FOR TREATMENT OF PATIENTS WITH PRIMARY ADVANCED/FIRST RECURRENT ENDOMETRIAL CANCERReuters
Tue, Feb 3
Relay Therapeutics Announces Zovegalisib Granted Therapy Designation By FDA For Pik3ca-Mutant
Feb 3 (Reuters) - Relay Therapeutics Inc RLAY.O:RELAY THERAPEUTICS ANNOUNCES ZOVEGALISIB GRANTED BREAKTHROUGH THERAPY DESIGNATION BY U.S. FDA FOR PIK3CA-MUTANT, HR+/HER2- ADVANCED BREAST CANCERReuters
Tue, Feb 3
Trump-backed deal to end shutdown faces tight House vote
By David Morgan WASHINGTON, Feb 3 (Reuters) - The Republican-controlled U.S. House of Representatives will try to pass a deal that would end the latest government shutdown on Tuesday over opposition from an unusual alignment of Democrats and hardline conservatives.The legislation would fund defen...Reuters
Tue, Feb 3
Replimune's Q3 net loss widens as R&D expenses rise
OverviewBiotechnology firm's fiscal Q3 net loss was $70.9 mln vs $66.3 mln a year agoCompany preparing for RP1 launch, pending FDA approvalLoan agreement amended to extend cash runway into Q1 2027OutlookReplimune expects FDA decision on RP1 by April 10, 2026Company extends cash runway into Q1 20...Reuters
Tue, Feb 3
Morris State Bancshares Q4 profit rises as NIM improves
OverviewGeorgia bank's Q4 net income decreased from Q3 but increased from Q4 2024Company declared increased quarterly dividend and special dividendCompany received regulatory approval for merger with Vallant FinancialOutlookCompany anticipates completing merger with Vallant Financial by March 20...Reuters
Tue, Feb 3
Ultragenyx: Long-Term UX111 Data Shows Sustained CSF-HS Reductions, Multi-Domain Gains In Children With Sanfilippo Syndrome (Mps Iiia)
Feb 3 (Reuters) - Ultragenyx Pharmaceutical Inc RARE.O:ULTRAGENYX ANNOUNCES POSITIVE LONGER-TERM DATA DEMONSTRATING TREATMENT WITH UX111 GENE THERAPY RESULTS IN SUSTAINED, SIGNIFICANT REDUCTIONS IN CSF-HS AND CONTINUED MEANINGFUL IMPROVEMENTS IN CLINICAL FUNCTION ACROSS MULTIPLE DEVELOPMENTAL DOMAIN...Reuters
Tue, Feb 3
Versabank Signed A Definitive Agreement With Stablecorp Digital Currencies Inc.
Feb 3 (Reuters) - VersaBank VBNK.TO:VERSABANK - SIGNED A DEFINITIVE AGREEMENT WITH STABLECORP DIGITAL CURRENCIES INC.VERSABANK: WILL EARN BOTH FEE BASED ON VALUE OF QCAD ASSETS HELD IN CUSTODY & SPREAD BASED ON QCAD DEPOSITSReuters
Tue, Feb 3
Grainger Q4 profit misses estimates as margins decline
OverviewBroad line distributor's Q4 revenue slightly beat analyst expectationsAdjusted EPS for Q4 missed analyst expectationsCompany issued 2026 outlook with 6.5%-9.0% organic sales growthOutlookGrainger expects 2026 daily, organic constant currency sales growth of 6.5% to 9.0%Grainger forecasts...Reuters
Tue, Feb 3
Mesa Laboratories Q3 revenue rises 3.6%
OverviewLife science tools maker's fiscal Q3 revenue rose 3.6% yr/yrOperating income for fiscal Q3 increased 38%Company repaid $8.7 mln of debt, reducing leverage ratio to 2.62OutlookMesa expects positive momentum to continue in 4Q26Company anticipates slight moderation in profitability margins ...Reuters
Tue, Feb 3
